Ernexa Therapeutics Inc.
ERNANasdaqCIK 748592HealthcareFiscal year ends Dec 31
Reports and events: 421 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-03-1416:36 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001140361-24-013254 |
| 2024-02-1607:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-24-008273 |
| 2024-01-1916:16 ET | 8-K | 3.01 Delisting notice | 0001140361-24-002915 |
| 2023-12-2212:05 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-23-128667 |
| 2023-12-2016:20 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-23-058648 |
| 2023-12-1416:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-23-057648 |
| 2023-11-1616:16 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-23-053659 |
| 2023-11-1308:30 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001140361-23-052742 |
| 2023-11-0108:34 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-23-050682 |
| 2023-10-0516:30 ET | 8-K | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001140361-23-047156 |
| 2023-09-2616:30 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001140361-23-045249 |
| 2023-09-0717:26 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-23-099002 |
| 2023-08-3116:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-23-042061 |
| 2023-08-1116:11 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001140361-23-039283 |
| 2023-08-1016:10 ET | 8-K | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors | 0001140361-23-039073 |
| 2023-08-0217:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-23-037681 |
| 2023-07-2617:05 ET | SC 13D/A | Ownership report, active investor, amended | 0001213900-23-060068 |
| 2023-07-1808:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001140361-23-034885 |
| 2023-07-1306:02 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-23-034310 |
| 2023-07-1116:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-23-034072 |
| 2023-06-2016:32 ET | 8-K | 5.07 Shareholder vote results | 0001140361-23-030499 |
| 2023-05-1116:34 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001140361-23-024180 |
| 2023-05-0507:00 ET | DEF 14A | Proxy statementPeriod 2023-06-16 | 0001140361-23-023073 |
| 2023-05-0506:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-23-023068 |
| 2023-05-0216:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001140361-23-022489 |
| 2023-04-1721:29 ET | S-1 | Registration statement | 0001140361-23-018529 |
| 2023-04-1107:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001140361-23-017671 |
| 2023-03-2016:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-23-012545 |
| 2023-03-2006:31 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001140361-23-012418 |
| 2023-02-2217:29 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001140361-23-008076 |
| 2023-01-2616:31 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-23-002909 |
| 2023-01-1016:30 ET | 8-K | 3.01 Delisting notice | 0001140361-23-001223 |
| 2023-01-0408:35 ET | 8-K | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-23-000340 |
| 2022-12-2016:30 ET | SC 13D | Ownership report, active investor | 0001140361-22-046379 |
| 2022-12-1416:30 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-22-045540 |
| 2022-12-0616:30 ET | 8-K | 1.02 Termination of a material agreement | 0001140361-22-044598 |
| 2022-12-0506:02 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-22-044329 |
| 2022-11-2506:01 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001140361-22-043061 |
| 2022-11-2306:15 ET | 8-K | 3.01 Delisting notice | 0001140361-22-042849 |
| 2022-11-2216:06 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-22-042770 |
| 2022-11-1416:32 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001140361-22-041399 |
| 2022-11-0916:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-22-040706 |
| 2022-10-2416:31 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001140361-22-038231 |
| 2022-10-1416:33 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-22-037240 |
| 2022-10-1108:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-22-036744 |
| 2022-09-2316:30 ET | 8-K | 5.07 Shareholder vote results | 0001140361-22-034533 |
| 2022-09-1516:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-22-033478 |
| 2022-09-0116:45 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-22-031997 |
| 2022-08-1216:15 ET | DEF 14A | Proxy statementPeriod 2022-09-21 | 0001140361-22-029433 |
| 2022-08-1116:16 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001140361-22-029251 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 14:05 ET. Listed shows no prices and gives no investment advice.